Skip to main content
. 2014 Jun 18;6(10):7493–7503. doi: 10.18632/oncotarget.2115

Table 1. Incidence Rates and Hazard Ratios (HR) for Event-Free Survival (EFS) and Overall Survival (OS); (N=102).

N Number (%) of relapses or deaths Incidence Rates
x 1000 (EFS)
HR
(P)
Number (%) of deaths Incidence Rates
× 1000 (OS)
HR
(P)
Age
≥ 18 months 44 25 (56.8%) 19.4 (13.1-28.7) 2.45 (P=0.017) 19 (43.2%) 12.3 (7.9-19.3) 3.2 (P=0.006)
< 18 months (reference) 58 16 (27.6%) 7.9 (4.8-12.9) 9 (15.5%) 3.9 (2.0-7.5)
Stage
4 31 20 (64.5%) 19.2 (12.4-29.8) 2.1 (P=0.004) 18 (58.1%) 15.1 (9.5-24.0) 4.0 (P<0.0001)
1, 2, 3, 4s (reference) 71 21 (29.6%) 9.2 (6.0-14.2) 10 (14.1%) 3.7 (2.0-7.0)
MYCN status
Amplified 44 25 (56.8%) 22.6 (15.3-33.4) 3.1 (P=0.004) 21 (47.7%) 17.1 (11.2-26.2) 6.4 (P<0.0001)
Not amplified (reference) 58 16 (27.6%) 7.25 (4.4-11.8) 7 (12.1%) 2.7 (1.3-5.6)
Ploidy
Diploid 49 26 (53.1%) 16.6 (11.3-24.4) 1.9 (P=0.029) 17 (34.7%) 9.0 (5.6-14.5) 1.6 (P=0.10)
Hyperdiploid (reference) 53 15 (28.3%) 8.6 (5.2-14.2) 11 (20.7%) 5.6 (3.1-10.1)
Histology
Unfavorable histology 50 30 (60.0%) 19.3 (13.5-27.7) 3.1 (P=0.001) 24 (48.0%) 13.2 (8.8-19.6) 6.7 (P<0.0001)
Favorable histology (reference) 52 11 (21.1%) 6.2 (3.45-11.3) 4 (7.7%) 2.0 (0.7-5.2)
Risk Group (N=86)
High/Intermediate 58 33 (56.9%) 19.4 (13.5-27.7) 4.8 (P=0.002) 27 (46.6%) 13.8 (9.5-20.1) 15.2 (P=0.0003)
Low (reference) 28 4 (14.3%) 4.0 (1.5-10.7) 1 (3.6%) 0.9 (0.1-6.5)
Telomere length
Long 46 27 (58.7%) 22.7 (15.6-33.2) 7.0 (P<0.0001) 19 (41.3%) 12.2 (7.8-19.1) 7.8 (P=0.0006)
Normal 13 8 (61.5%) 27.75 (13.9-55.5) 8.5 6 (46.1%) 16.0 (7.2-35.6) 10.2
Short (reference) 43 6 (13.9%) 3.26 (1.5-7.3) 3 (7.0%) 1.6 (0.5-4.8)
h-TERT (N=99)
> 0.398 (> 0.205) 31 21 (67.7%) 26.1 (17.0-40.1) 3.8 (P<0.0001) 23/61 (37.7%) 10.6 (7.0-16.0) 5.9 (P=0.003)
≤ 0.398 (≤ 0.205) 68 17 (25.0%) 6.8 (4.3-11.0) 3/38 (7.9%) 1.8 (0.6-5.7)
ALT mechanism
Positive 60 28 (46.7%) 15.1 (10.4-21.9) 1.7 (P=0.11) 21 (35.0%) 9.5 (6.2-14.5) 2.2 (P=0.035)
Negative 42 13 (30.9%) 8.9 (5.2-15.3) 7 (16.7%) 4.3 (2.0-9.0)

P values refer to the Log-Rank test.